Trial sequential analysis of the efficacy of Fasudil in Chinese patients with pulmonary hypertension

Journal of the American College of Cardiology(2015)

引用 0|浏览18
暂无评分
摘要
Activation of Rho-A/Rho-kinase pathway found recently is one of the pathogenic mechanisms on pulmonary hypertension. It is necessary to evaluate the efficacy of Rho-kinase inhibitor Fasudil for the treatment of pulmonary hypertension based on principle of Meta-analysis and trial sequential analysis
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要